首页> 外文期刊>American Journal of Cancer Research >Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages
【24h】

Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages

机译:血管生成素样蛋白2通过促进M2肿瘤相关巨噬细胞的极化促进非小细胞肺癌的进展

获取原文
           

摘要

The functional phenotypes (M1 and M2) of tumor-associated macrophages (TAMs) are influenced by the tumor microenvironment (TME) and contribute greatly to the development of non-small cell lung cancer (NSCLC). However, the molecular mechanisms for TAM polarization remain unclear. Angiopoietin-like protein 2 (Angptl2) is involved in tumor progression. In this study, Angptl2 expression was aberrantly increased in NSCLC cells and positively correlated with TAM infiltration, tumor size and poor patient survival. Moreover, in vitro tumor cell-macrophage co-culture and recombinant protein stimulation revealed that Angptl2 fostered the M2 polarization of TAMs through the p65 nuclear factor-kappa B (NF-ĸB) pathway. In addition, Angptl2-promoted TAM enhanced proliferation, invasion, and migration of NSCLC cells and the tube formation of human umbilical vein endothelial cells (HUVECs). In vivo, TAM depletion inhibited the tumor growth induced by Angptl2. Here, for the first time, we determined that Angptl2 promoted the M2 polarization of TAMs and enhanced NSCLC progression. Interfering with Angptl2 might be an effective strategy for reprogramming TAM polarization in NSCLC, providing a promising therapy for NSCLC treatment.
机译:肿瘤相关巨噬细胞(TAM)的功能表型(M1和M2)受肿瘤微环境(TME)的影响,并极大地促进了非小细胞肺癌(NSCLC)的发展。但是,TAM极化的分子机制仍不清楚。血管生成素样蛋白2(Angptl2)参与肿瘤进展。在这项研究中,Angptl2表达在NSCLC细胞中异常增加,并且与TAM浸润,肿瘤大小和患者生存不良呈正相关。此外,体外肿瘤细胞-巨噬细胞共培养和重组蛋白刺激显示,Angptl2通过p65核因子-κB(NF-ĸB)途径促进了TAM的M2极化。此外,Angptl2促进的TAM增强了NSCLC细胞的增殖,侵袭和迁移以及人脐静脉内皮细胞(HUVEC)的管形成。在体内,TAM耗竭抑制了Angptl2诱导的肿瘤生长。在这里,我们首次确定Angptl2促进了TAM的M2极化并增强了NSCLC进程。干扰Angptl2可能是重编程NSCLC中TAM极化的有效策略,为NSCLC治疗提供了有希望的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号